Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease mental depression
Phenotype C0006142|breast cancer
Sentences 50
PubMedID- 25761086 Trajectories of distress, anxiety, and depression among women with breast cancer: looking beyond the mean.
PubMedID- 24077731 Pharmacological treatment of depression in women with breast cancer: a systematic review.
PubMedID- 26516588 Now established agents such as trastuzumab (herceptin), a monoclonal antibody targeted against mutant forms of the her2/neu receptor licensed for use against some forms of breast cancer, are associated with cardiac depression and an increase in adverse outcomes when combined with other anticancer agents with known cardiotoxicity risks (seidman et al.
PubMedID- 23346176 The specific aims of the current study were to examine the unmet needs and depression among patients with recurrent breast cancer and to explore the predictive value of unmet needs on qol along with socio-demographic and clinical variables.
PubMedID- 24337537 Some evidence suggests that a decrease in depression in patients with metastatic breast cancer is associated with lower mortality [42].
PubMedID- 22699176 Further studies are needed to identify the effect on emotions such as anxiety and depression for women with breast cancer with above average levels of anxiety and depression.
PubMedID- 23217093 In the multicenter randomized prospective trial breast cancer patients with comorbid depression who fulfill inclusion criteria either get stpp or tau.
PubMedID- 26508964 The individual effects of bdnf promoter methylation percentages on depression in patients with breast cancer at the two evaluations were tested using multivariate logistic regression models after adjustment for those sociodemographic and clinical characteristics that were significantly associated with depression at 1 week or 1 year after breast surgery (p<0.05).
PubMedID- 21567239 Sleep duration among breast cancer survivors correlates with fatigue, depression, and health-related quality of life (hrqol); however, this has not been studied longitudinally.
PubMedID- 25674442 The use of selected serotonin reuptake inhibitors (ssri’s), anti-depressives used to treat both hot flashes and depression in women with breast cancer, has recently been the focus of controversy.
PubMedID- 20814770 Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy.
PubMedID- 24362868 Treatment of depression in patients with breast cancer: a critical review.
PubMedID- 20446075 Background: depression in breast cancer (bca) patients can reduce quality of life, relationships and treatment compliance, thus constituting a major target for cognitive behavioural (cbt) interventions.
PubMedID- 26347018 To the best of our knowledge, this is the first randomised controlled clinical trial to simultaneously assess the effectiveness of a combined pmr and gi program in managing anxiety and depression in patients with prostate and breast cancer receiving chemotherapeutic agents.
PubMedID- 24347520 The purpose of this trial was to determine the efficacy of short-term psychodynamic psychotherapy (stpp) in non-metastatic breast cancer patients diagnosed with depression, one of the most frequent mental comorbidities of breast cancer.
PubMedID- 20385344 Several psychotherapeutic modalities offer relief of the symptoms and syndromes of depression in breast cancer.
PubMedID- 25788991 In a cohort study investigating breast cancer outcomes in patients with depression, only 51% of the study group (breast cancer patients with depression) accepted and commenced chemotherapy, compared with 92% of the control group (breast cancer patients without depression) (4).
PubMedID- 22409643 Anxiety and depression in breast cancer survivors of different sexual orientations.
PubMedID- 21462281 Conclusion: our study suggests a high rate of associated depression among patients with breast cancer in our environment.
PubMedID- 24243809 Eysenck personality questionnaire revised psychoticism predicts motivational-somatic symptoms of depression in breast cancer survivors.
PubMedID- 23731173 Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients.
PubMedID- 25780852 Conclusions: the level of anxiety and depression among women with breast cancer was influenced by the type of the applied surgical procedure and adjuvant chemotherapy.
PubMedID- 23512358 Radiation is an essential component of breast-conserving therapy and may contribute to depression in patients with breast cancer through the activation of inflammatory pathways.
PubMedID- 23967823 However, due to a few of studies (the number is less than or equal to 3) separately reporting the or for depression and anxiety in patients with breast cancer, lung cancer, liver cancer, the subgroup comparison of depression and anxiety in different types of cancer patients were not analyzed.
PubMedID- 23725190 Prevalence of depression in breast cancer survivors: a systematic review of observational studies.
PubMedID- 21867502 A systematic review found high rates of probable depression in breast cancer patients (10% to 25%) [13].
PubMedID- 25960844 Effectiveness of group training based on acceptance and commitment therapy on anxiety and depression of women with breast cancer.
PubMedID- 23646866 Methods: sixty-two breast cancer patients diagnosed with major depression were randomly assigned to gcbt group (n = 31) or a waiting list control group provided with an educational booklet (n = 31).
PubMedID- 25806355 In addition, breast cancer patients with depression have typically been excluded from studies (5, 8, 17, 18, 20–24, 27, 31–36), or these factors were statistically controlled for (7, 26, 38).
PubMedID- 19458878 What do predict anxiety and depression in breast cancer patients.
PubMedID- 23124416 Influence of age, performance status, cancer activity, and il-6 on anxiety and depression in patients with metastatic breast cancer.
PubMedID- 23604452 Icf, quality of life, and depression in breast cancer: perceived disability in disease-free women 6 months after mastectomy.
PubMedID- 24007891 This case highlights the incidence of depression in persons with breast cancer, examines the controversy of tamoxifen-induced depression, and evaluates antidepressant considerations regarding potentially efficacy-reducing cytochrome p450 2d6 drug interactions with tamoxifen.
PubMedID- 21054923 Sexual abuse in childhood and postoperative depression in women with breast cancer who opt for immediate reconstruction after mastectomy.
PubMedID- 23265707 Purpose: to test the effect of such a programme on anxiety and depression among women with breast cancer in a population-based randomised controlled study.
PubMedID- 23865135 Objective: to investigate the prevalence of depression in women with breast cancer and relate it to their health-related quality of life.
PubMedID- 25954147 (2013) investigated fatigue and depression symptoms in patients with breast cancer.
PubMedID- 25201115 Cancer-related fatigue and depression in breast cancer patients postchemotherapy: different associations with optimism and stress appraisals.
PubMedID- 26453348 These results suggest that ipt is a promising treatment for depression in women with breast cancer.
PubMedID- 26009671 Aim: to compare the effects of yoga program with supportive therapy on self-reported symptoms of depression in breast cancer patients undergoing conventional treatment.
PubMedID- 25377647 Here, we review the prevalence and treatment of anxiety and depression among patients with breast cancer.
PubMedID- 25684491 Associations among physical activity, comorbidity, functional capacity, peripheral muscle strength and depression in breast cancer survivors.
PubMedID- 25543421 [efficacy on depression in breast cancer treated with acupuncture and auricular acupressure].
PubMedID- 25111433 Although several outcome studies have explored the utility of psychotherapy for breast cancer patients with subsyndromal depression symptoms, only a few clinical trials have explored the efficacy of behavior therapy for patients with well-diagnosed mdd.
PubMedID- 20142325 The prevalence of depression in women with early breast cancer is roughly twice that of the general female population and is particularly high around the time of diagnosis.39 in our study, 30% of women who started tamoxifen treatment also received antidepressants, and paroxetine was the most commonly used ssri.
PubMedID- 22888085 depression in breast cancer patients and survivors is related to negative disease outcomes and worse quality of life.
PubMedID- 26035180 breast cancer patients with a depression diagnosis also had lower mortality (or=0.69, 95% ci: 0.52-0.89) compared with those without a depression diagnosis, but there was no significant difference in mortality among those with and without anxiety diagnoses.
PubMedID- 20602189 A randomized trial of bupropion vs. other antidepressants, both at standard and lower doses (similar to those used for hot flash management), would provide valuable information and offer options for breast cancer patients with both depression and sexual dysfunction.
PubMedID- 23041586 Conclusions: exercise intervention improved fatigue, depression, and qol in patients with breast cancer receiving adjuvant therapy.
PubMedID- 25287728 Methods: seventy-seven breast cancer patients with comorbid depression were evaluated with the hamilton depression rating scale (hamd), the clinical global impression-severity of illness (cgi-s) for depression, and the functional assessment of cancer therapy-breast (fact-b).

Page: 1